Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

iShares S&P/TSX North American Preferred Stock Index ETF (CAD-Hedged) + Watchlist XPF CA Closed Last Updated: Jun 12, 2025 11:04 a.m. EDT Delayed quote $ 15.24-0.01-0.07% Previous Close $15.25 ...

Addeddate 2025-06-12 06:08:09 Collection_added cd-roms vintagesoftware Identifier cdrinc_AutoCAD_Resource_Guide_ESX_Interactive Scanner Internet Archive Python library 4.1.0 ...

There was an error while loading. Please reload this page.